CLSI AST News Updates
The CLSI Outreach Working Group (ORWG), under CLSI's Subcommittee on Antimicrobial Susceptibility Testing (AST), works to efficiently convey information regarding contemporary AST practices, recommendations, and resources to the clinical microbiology community. This biannual CLSI AST News Update highlights current issues related to antimicrobial susceptibility testing (AST) and reporting.
Volume 9, Issue 1, January 2024
Edited By: Janet A. Hindler, MCLS, MT(ASCP), F(AAM) & Audrey N. Schuetz, MD, MPH, D(ABMM)
View all of the articles below in one PDF by clicking below.
Featured Article
Acinetobacter—The Bad, the Awful, and the Downright Ugly
Case Study
Antifungal Body Site Reporting for Candida spp.
Practical Tips
Practical Tips for Using Newly Formatted Tables 1 in CLSI M100 33rd Edition
Hot Topic
Sulbactam-Durlobactam: The “double beta-lactamase inhibitor” drug
CLSI and the AST Subcommittee
CLSI has subcommittees that are responsible for areas related to AMR. They write draft documents, evaluate and respond to comments on content throughout the document development process, conduct scheduled document reviews, and may be responsible for continual revision of certain documents.
CLSI's AST Subcommittee meets twice per year in a hybrid format (in-person with a virtual component) in January and June. More information can be found in the links below.
How to Get Involved
Working groups are managed by chairholders. If you would like to volunteer to become a member of a working group, please fill out our form below. You can also complete your Volunteer Profile to be placed in the "potential volunteers pool" for future positions.
I’m interested! What are my next steps?
Free Resources From CLSI
CLSI Free M100 and M27M44S
Performance Standards for Antimicrobial & Antifungal Susceptibility Testing
Access read-only web versions of M100 and M27M44S for free and quickly reference the most trusted AST and antifungal breakpoints. Available online as a convenient companion to our M100 document and M27M44S document.
CLSI Using M100-Ed32
Using M100: Performance Standards for Antimicrobial Susceptibility Testing
Improve your lab's antimicrobial susceptibility testing (AST) by using this self-paced, online learning program. This interactive program will teach you how to navigate the many tables found in CLSI's document M100.
CLSI M53
Criteria for Laboratory Testing and Diagnosis of Human Immunodeficiency Virus Infection, 2nd Edition
This guideline includes recommendations for performing human immunodeficiency virus testing and for interpretation of results by health care providers in advanced diagnostic laboratories.
On-Demand Webinars | Recently archived CLSI webinars can be accessed on demand and after six months are free unless noted otherwise.
CLSI On-Demand M39 Webinar
M39: Analysis and Presentation of Cumulative Antimicrobial Susceptibility Test Data Webinar
Learn about CLSI's updated M39 document, Analysis and Presentation of Cumulative Antimicrobial Susceptibility Test Data.
CLSI Free On Demand: Rationale Webinar
FDA’s Role in ASTs and Understanding CLSI Breakpoint Decisions Webinar
December 17, 2020 | 1:00-2:00 PM Eastern (US) Time
AST Subcommittee Partnerships
Representatives with expertise in antimicrobials from the following organizations attend and participate in CLSI AST Subcommittee meetings and aid in dissemination of information regarding CLSI decisions and AST issues.
- American College of Clinical Pharmacy
- Infectious Diseases Practice and Research Network (ACCP INFD PRN)
- American Society for Microbiology (ASM)
- Association of Public Health Laboratories (APHL)
- ASTM International
- College of American Pathologists (CAP)
- European Committee on Antimicrobial Susceptibility Testing (EUCAST)
- Infectious Diseases Society of America (IDSA)
- Pediatric Infectious Diseases Society (PIDS)
- Society for Healthcare Epidemiology of America (SHEA)
- Society of Infectious Diseases Pharmacists (SIDP)
- Susceptibility Testing Manufacturers Association (STMA)